Tysabri may be possible for more MS patients with new test

[MSUK]

A blood test for L-selectin expression on circulating immune cells may identify multiple sclerosis patients who could safely receive natalizumab (Tysabri) despite past exposure to the JC virus, a small study presented here suggested.

All MS patients taking natalizumab who developed the rare but life-threatening brain inflammation called progressive multifocal leukoencephalopathy (PML) in the study had very low levels of L-selectin expression, which was not seen in other patients who did not develop PML or in controls, said Heinz Wiendl, MD, of the University of Muenster in Germany...... Read More - http://www.ms-uk.org/tysabri

[HarryZ]

Wiendl reported relationships with Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi, Teva, and Novo Nordisk.

All the MS drug manufacturers! Guess whose benefit he is working for?!

In this case, Biogen looks like they are doing everything they can to increase that market share for Ty$abri.

Harry